Expanded Access Program for Participants Who Completed Study 13-601 and Continue to Clinically Benefit From Cerdulatinib
Clinical trial NCT04757259 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT04757259
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.